| Previous close | 69.81 |
| Open | 69.88 |
| Bid | 0.00 x 120700 |
| Ask | 0.00 x 6100 |
| Day's range | 69.14 - 69.90 |
| 52-week range | 63.62 - 80.07 |
| Volume | 1,213,948 |
| Avg. volume | 1,093,384 |
| Market cap | 38.66B |
| Beta | N/A |
| PE ratio (TTM) | 21.84 |
| EPS (TTM) | 3.19 |
| Earnings date | 2 Nov 2017 |
| Dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Thomson Reuters StreetEvents•last month
Edited Transcript of FRE.DE earnings conference call or presentation 1-Aug-17 12:00pm GMT
Q2 2017 Fresenius SE & Co KGaA Earnings Call
Zacks•last monthBioScrip (BIOS) Shows Strength: Stock Adds 6.6% in Session
BioScrip, Inc. (BIOS) moved big last session, as its shares jumped almost 7% on the day.
- Zacks•last month
Fresenius Medical Inks $2B Deal to Take Over NxStage Medical
Fresenius Medical's (FMS) latest development is expected to fortify the company's foothold in the Home dialysis market, particularly in the renal care space.
